Tumour Escape from CAR-T Cells
Open Access
- 7 February 2022
- book chapter
- Published by Springer Nature
- p. 15-22
Abstract
Over the past decade, CAR-T cells have emerged as one of the most powerful cellular immune therapy approaches in the battle against haematological malignancies. Nonetheless, similar to other immunotherapeutic approaches, tumour cells develop strategies to evade CAR-T cell therapy, often with the support of a highly immunosuppressive and protective tumour microenvironment. To date, antigen loss, immune dysfunction, exhaustion and (microenvironment-mediated) upregulation of antiapoptotic pathways have been identified as major modes of tumour escape from CAR-T cell therapy. This chapter will focus on our current understanding of these modes of immune escape from CAR-T cells.Keywords
Funding Information
- European Society for Blood and Marrow Transplantation
- The European Hematology Association
This publication has 38 references indexed in Scilit:
- Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFNγCancer Research, 2014
- Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid TumorsClinical Cancer Research, 2014
- Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune ResistanceClinical Cancer Research, 2013
- Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancyCancer Gene Therapy, 2013
- Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune functionBlood, 2012
- Granzymes in cancer and immunityCell Death & Differentiation, 2010
- Following TRAIL’s path in the immune systemImmunology, 2009
- Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemiaBlood, 2003
- Apoptosis without caspases: an inefficient molecular guillotine?Cell Death & Differentiation, 1999
- Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.Proceedings of the National Academy of Sciences, 1994